fig3

CF10/LV overcomes acquired resistance to 5-FU/LV in colorectal cancer cells through downregulation of the c-Myc/ABCB5 axis

Figure 3. 5-FU/LV (10 mM, 1 mM) and CF10/LV (1 mM, 1 mM) treatment for 24 h increase TS at both the protein (A and B) and mRNA (C) levels in HCT116R cells, but only CF10/LV promotes ternary complex formation (TSCC) and efficient inhibition of TS enzymatic activity (D). *P < 0.03; ****P < 0.0001. Figure preparation software is GraphPad Prism (RRID: SCR_002798). 5-FU: 5-Fluorouracil; LV: leucovorin; TS: thymidylate synthase; TSCC: TS classic complex.

Cancer Drug Resistance
ISSN 2578-532X (Online)

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/